Goetz C - Search Results

1

A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.

Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, Pagano M; Parkinson Study Group. Blindauer K, et al. Among authors: goetz c. Arch Neurol. 2006 Feb;63(2):210-6. doi: 10.1001/archneur.63.2.210. Arch Neurol. 2006. PMID: 16476809 Clinical Trial.

2

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.

Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, et al. Jankovic J, et al. Among authors: goetz c. Neurology. 1990 Oct;40(10):1529-34. doi: 10.1212/wnl.40.10.1529. Neurology. 1990. PMID: 2215943

3

Drug-induced Parkinsonism and idiopathic Parkinson's disease.

Goetz CG. Goetz CG. Arch Neurol. 1983 May;40(5):325-6. doi: 10.1001/archneur.1983.04050050093019. Arch Neurol. 1983. PMID: 6133514 No abstract available.

4

Pramipexole in patients with early Parkinson's disease.

Hubble JP, Koller WC, Cutler NR, Sramek JJ, Friedman J, Goetz C, Ranhosky A, Korts D, Elvin A. Hubble JP, et al. Among authors: goetz c. Clin Neuropharmacol. 1995 Aug;18(4):338-47. doi: 10.1097/00002826-199508000-00006. Clin Neuropharmacol. 1995. PMID: 8665547 Clinical Trial.

5

Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.

Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Hiner BC, Jankovic J, Ondo WG, Allen FH Jr, Scott BL, Goetz CG, Small GW, Mastaglia FL, Stajich JM, Zhang F, Booze MW, Reaves JA, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM, Martin ER. Oliveira SA, et al. Among authors: goetz cg. Arch Neurol. 2003 Jul;60(7):975-80. doi: 10.1001/archneur.60.7.975. Arch Neurol. 2003. PMID: 12873854

6

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.

Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. Olanow CW, et al. Among authors: goetz cg. Ann Neurol. 2003 Sep;54(3):403-14. doi: 10.1002/ana.10720. Ann Neurol. 2003. PMID: 12953276 Clinical Trial.

7

Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).

Olanow CW, Damier P, Goetz CG, Mueller T, Nutt J, Rascol O, Serbanescu A, Deckers F, Russ H. Olanow CW, et al. Among authors: goetz cg. Clin Neuropharmacol. 2004 Mar-Apr;27(2):58-62. doi: 10.1097/00002826-200403000-00003. Clin Neuropharmacol. 2004. PMID: 15252265 Clinical Trial. No abstract available.

8

Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.

Goldman JG, Goetz CG, Berry-Kravis E, Leurgans S, Zhou L. Goldman JG, et al. Arch Neurol. 2004 Aug;61(8):1280-4. doi: 10.1001/archneur.61.8.1280. Arch Neurol. 2004. PMID: 15313848

9

A responsive outcome for Parkinson's disease neuroprotection futility studies.

Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K; NET-PD Investigators. Elm JJ, et al. Among authors: goetz cg. Ann Neurol. 2005 Feb;57(2):197-203. doi: 10.1002/ana.20361. Ann Neurol. 2005. PMID: 15668964

10

Hallucinations in Parkinson disease in the prelevodopa era.

Fénelon G, Goetz CG, Karenberg A. Fénelon G, et al. Neurology. 2006 Jan 10;66(1):93-8. doi: 10.1212/01.wnl.0000191325.31068.c4. Neurology. 2006. PMID: 16401853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

885 results

Search Page

Filters